We are preparing the requested document. Please wait, this may take a while...!
|Antigen||CD4 Molecule (CD4) Antibodies|
|Epitope||Extracellular Domain Alternatives|
|Conjugate||This CD4 antibody is un-conjugated Alternatives|
Cytometry by Time of Flight (CyTOF), Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunohistochemistry (IHC)
|4 references available|
|Supplier||Log in to see|
Product Details anti-CD4 AntibodyTarget Details CD4 Application Details Handling References for anti-CD4 antibody (ABIN4900531) Images
|Specificity||Detects human CD4 in direct ELISAs and Western blots. In direct ELISAs, less than 1 % cross-reactivity with recombinant mouse CD4 is observed.|
|Purification||Protein A or G purified from ascites|
|Sterility||0.2 μm filtered|
|Immunogen||S. frugiperda insect ovarian cell line Sf 21-derived recombinant human CD4, Extracellular domain|
|Plasmids, Primers & others|
Target Details CD4Product Details anti-CD4 Antibody Application Details Handling References for anti-CD4 antibody (ABIN4900531) Images back to top
|Alternative Name||CD4 (CD4 Antibody Abstract)|
|Background||Alternative Names: CD4, CD4 antigen, CD4 antigen (p55), CD4 Molecule, CD4 receptor, CD4mut, T-cell surface antigen T4/Leu-3, T-cell surface glycoprotein CD4|
|Pathways||TCR Signaling, Maintenance of Protein Location, CXCR4-mediated Signaling Events|
Application DetailsProduct Details anti-CD4 Antibody Target Details CD4 Handling References for anti-CD4 antibody (ABIN4900531) Images back to top
Flow Cytometry 2.5 μg/10^6 cells
Immunohistochemistry 8-25 μg/mL
Immunocytochemistry 8-25 μg/mL
|Restrictions||For Research Use only|
HandlingProduct Details anti-CD4 Antibody Target Details CD4 Application Details References for anti-CD4 antibody (ABIN4900531) Images back to top
|Reconstitution||Reconstitute at 0.5 mg/mL in sterile PBS.|
|Buffer||Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.|
|Storage||4 °C,-20 °C,-80 °C|
|Storage Comment||Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt,-20°C to -70°C as supplied. 1 month,2°C to 8°C under sterile conditions after reconstitution. 6 months,-20°C to -70°C under sterile conditions after reconstitution.|
|Expiry Date||12 months|
References for anti-CD4 antibody (ABIN4900531)Product Details anti-CD4 Antibody Target Details CD4 Application Details Handling Images back to top
|Product cited in:||
Chimote, Hajdu, Sfyris, Gleich, Wise-Draper, Casper, Conforti: "Kv1.3 Channels Mark Functionally Competent CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer." in: Cancer research, Vol. 77, Issue 1, pp. 53-61, 2016 Method employed by authors: Immunohistochemistry (IHC) (Sample species: Human).
Suzuki, Kubota, Miyazaki, Ishikawa, Ebisawa, Hirohata, Ogura, Mizusawa, Imai, Miyasaka, Nanki: "Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity." in: Arthritis research & therapy, Vol. 14, Issue 2, pp. R48, 2012 Method employed by authors: Immunohistochemistry (Frozen Sections) (IHC (fro)) (Sample species: Human).
Nezlin, Bengtsson: "Presence of IgG-CD4 complexes in the circulation." in: Immunological investigations, Vol. 37, Issue 2, pp. 153-62, 2008 Method employed by authors: Dot Blot (DB) (Sample species: Human).
Schaecher, Diamond, Pekosz: "The transmembrane domain of the severe acute respiratory syndrome coronavirus ORF7b protein is necessary and sufficient for its retention in the Golgi complex." in: Journal of virology, Vol. 82, Issue 19, pp. 9477-91, 2008 Method employed by authors: Western Blotting (WB) (Sample species: Human).
ImagesProduct Details anti-CD4 Antibody Target Details CD4 Application Details Handling References for anti-CD4 antibody (ABIN4900531) back to top